Namibian Oncology Centre
Privately owned tertiary oncology and cancer-care provider serving Namibia from facilities in Windhoek and Swakopmund.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
The Namibian Oncology Centre (NOC) is a privately owned, specialized tertiary-care oncology provider in Namibia. Established in 2015, it was created to expand the country’s domestic capacity for cancer treatment, complement the public Dr AB May Cancer Treatment Centre at Windhoek Central Hospital, and reduce the need for private patients to travel to South Africa for radiotherapy and related services. Before NOC began operating, Namibian patients requiring radiation treatment commonly had to seek care outside the country. NOC began serving patients in 2015 with a combination of oncology pharmacy, radiation treatment, chemotherapy, and rehabilitative services. Radiotherapy became available in July 2015, followed by oncology pharmacy and chemotherapy services in November of the same year. Its digital linear accelerator was described as the first of its kind in Namibia, making the centre an important addition to the country’s specialist medical infrastructure. The centre also serves some patients referred from neighboring countries, including Angola. The organization operates multiple facilities. Its two Windhoek locations are the Khomasdal facility, at the intersection of Mahatma Gandhi Street and Hans Dietrich Genscher Street, and the Eros facility. The Eros site includes radiation and ward access at 3 Heliodoor Street, while consultation and chemotherapy services are accessed from 5, 7, and 9 Omaruru Street. NOC also operates a facility on Henties Bay Road in Swakopmund. A fourth centre is under construction at Erf 3274 near Ongwediva Medipark, with an anticipated opening in August 2026; that date is a planned target rather than a confirmed operating date. NOC’s service model combines clinical oncology, radiation oncology, chemotherapy administration, medicines management, inpatient care, and rehabilitation. As of 2016, the organization maintained a private inpatient ward with 12 beds. By October 2025, it was reported to employ approximately 78 people, including oncologists, nurses, physicians, and therapists. The centre’s role is particularly significant in a country where cancer care must address a range of diseases including skin cancer, Kaposi’s sarcoma, breast cancer, prostate cancer, cervical cancer, and oral-cavity cancer. NOC is not a publicly listed company and no parent group or controlling corporate owner is identified in the available reference material beyond its description as being owned by a consortium of private individuals. Its public-facing identity is centered on specialist cancer treatment and the development of local oncology capacity in Namibia rather than on consumer products. The organization’s operating footprint remains primarily Namibian, although its specialist facilities also support cross-border referrals within Southern Africa.
History
The Namibian Oncology Centre was established in 2015 against a background of limited domestic access to advanced cancer treatment. Patients in Namibia who required radiation services had previously needed to travel to South Africa, creating additional financial, logistical, and emotional burdens for patients and families. NOC was developed as a private-sector response intended to broaden national capacity and complement the Dr AB May Cancer Treatment Centre at Windhoek Central Hospital, the country’s principal public cancer-treatment facility. The centre began public operations in 2015. Radiotherapy services were introduced in July, and oncology pharmacy and chemotherapy services followed in November. The installation of a digital linear accelerator was a significant technological milestone because it was identified as the first such machine in Namibia. By providing radiation treatment domestically, NOC helped establish a private alternative for patients who might otherwise have required cross-border care. The centre’s services were also available to some patients referred from neighboring states, including Angola. NOC developed as more than a radiation facility. Its service offering came to include chemotherapy, oncology pharmacy, consultations, rehabilitation, and inpatient care. A private ward with 12 beds was reported in 2016, indicating that the organization had established an inpatient component relatively early in its operating history. The combination of treatment, medicines, nursing, physician services, and therapy supported a broader cancer-care pathway within one specialist organization. The centre’s physical network expanded beyond its original Windhoek base. It maintains two Windhoek sites, in Khomasdal and Eros, and a further facility in Swakopmund. The Eros location accommodates radiation and ward functions as well as consultation and chemotherapy access across its associated addresses. The Swakopmund site extends the organization’s reach beyond the capital and supports access for patients in the coastal region. NOC has also pursued further geographic expansion. Construction of a fourth centre at Erf 3274 near Ongwediva Medipark was reported as ongoing, with an anticipated opening in August 2026. Because the opening date is a forward-looking project estimate, its completion and operating status require later verification. The organization’s development reflects the wider oncology needs of Namibia. Reference material identifies skin cancer, Kaposi’s sarcoma, breast cancer, prostate cancer, cervical cancer, and oral-cavity cancer among prevalent or significant cancer categories in the country. NOC’s private specialist model is therefore positioned within a broader national effort to improve timely access to diagnosis, treatment, supportive care, and rehabilitation. As of October 2025, NOC was reported to employ approximately 78 staff members, including oncologists, nurses, physicians, and therapists. No individual founder, chief executive, board, parent corporation, or listed-company affiliation is identified in the available material. Ownership is described generally as a consortium of private individuals. The centre remains an active Namibian healthcare organization with a primary domestic footprint and some regional referral activity.
- 2026
Planned Ongwediva centre
[1]A fourth facility was under construction near Ongwediva Medipark and was anticipated to open in August 2026. The planned opening remains subject to confirmation.
- 2025
Workforce reported at approximately 78 employees
[1]As of October 2025, the centre was reported to employ about 78 people, including oncologists, nurses, physicians, and therapists.
- 2016
Private inpatient ward documented
[1]NOC was reported to operate a private inpatient ward with 12 beds.
- 2015
Namibian Oncology Centre established
[1]NOC was established as a privately owned specialist oncology provider intended to expand Namibia’s domestic cancer-treatment capacity and reduce reliance on treatment in South Africa.
- 2015
Radiotherapy services begin
[1]The centre began offering radiotherapy in July 2015, using a digital linear accelerator described as Namibia’s first.
- 2015
Chemotherapy and oncology pharmacy added
[1]Oncology pharmacy and chemotherapy services became available in November 2015, broadening the centre beyond radiation treatment.
Products and positioning
A private specialist oncology network focused on bringing radiotherapy, chemotherapy, pharmacy, rehabilitation, and related tertiary cancer services closer to patients in Namibia while also accepting selected regional referrals.
Cancer treatment · 2015
Radiotherapy
NOC provides radiation treatment as part of its specialist oncology offering. The service began in July 2015 and uses a digital linear accelerator described in the reference material as the first in Namibia. Radiotherapy is delivered through the centre’s Windhoek Eros operations and is intended to provide local access to treatment that previously required many patients to travel to South Africa.
Cancer treatment · 2015
Chemotherapy
Chemotherapy is one of NOC’s core clinical services. It was introduced in November 2015 alongside the oncology pharmacy. The service forms part of the centre’s broader treatment pathway, which combines specialist consultations, medicines management, nursing, and other supportive services for patients receiving cancer care.
Pharmacy services · 2015
Oncology pharmacy
NOC operates an oncology pharmacy supporting the preparation and supply of medicines associated with cancer treatment. The pharmacy service was introduced in November 2015 and is integrated with the centre’s chemotherapy and specialist oncology activities.
Supportive care
Cancer rehabilitation
Cancer rehabilitation is part of NOC’s stated service scope. It complements active treatment by supporting patients’ recovery and functioning through therapy and related clinical care. The available material does not specify the full range of rehabilitation programs or their individual launch dates.
Hospital care
Inpatient oncology care
The centre provides private inpatient oncology care. A 12-bed ward was documented in 2016, alongside the organization’s outpatient radiation, chemotherapy, pharmacy, consultation, and rehabilitation services. Current bed capacity is not specified in the available reference material.
Brand decisions
2026
Expand to OngwedivaStrategyBackground
NOC’s existing network consists of two Windhoek locations and a Swakopmund facility, leaving an opportunity to extend specialist oncology access to northern Namibia.
Action taken
The organization began constructing a fourth centre at Erf 3274 near Ongwediva Medipark, with an anticipated opening in August 2026.
Aftermath
The project was expected to broaden NOC’s geographic reach, but completion and opening had not been confirmed in the available material.
2015
Create domestic private oncology capacityStrategyBackground
Namibian patients requiring radiotherapy had previously needed to travel to South Africa, while the public cancer-treatment system also faced demand for specialist services.
Action taken
NOC was established as a private tertiary oncology centre offering radiotherapy, chemotherapy, oncology pharmacy, rehabilitation, and related cancer-care services within Namibia.
Aftermath
The centre began treating patients in 2015 and also became a destination for some regional referrals, including patients from Angola.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/namibian-oncology-centre · Editorial policy · How profiles are compiled